Opalia Recordati

Opalia Recordati is a leading Tunisian pharmaceutical company and a subsidiary of the Italian Recordati Group. Founded in 1988 as Opalia Pharma, it was acquired by Recordati in 2013 to serve as a strategic platform for growth in North Africa and the Middle East. The company specializes in the development, manufacturing, and commercialization of branded generic pharmaceuticals across diverse therapeutic areas, including dermatology, gastroenterology, and respiratory medicine. Operating from a modern, GMP-certified facility in Kalaat El Andalous, Opalia Recordati produces a wide range of dosage forms such as solids, semi-solids, and liquids. The company is recognized for its strong local market presence and its role in exporting high-quality medicines to neighboring regions.